Latest News about BIIB
Recent news which mentions BIIB
   Why Acumen Pharmaceuticals Stock Is Soaring Today
   
  
  
  September 28, 2022
  From Benzinga
 
   Why Is Cassava Sciences (SAVA) Stock Heating Up Today?
   
  
  
  September 28, 2022
  From InvestorPlace
 
   Why Is Biogen (BIIB) Stock Up 40% Today?
   
  
  
  September 28, 2022
  From InvestorPlace
 
   Medicare coverage of Eisai and Biogen’s promising new Alzheimer’s therapy is ‘another bridge to cross’
   
  
  
  September 28, 2022
  From MarketWatch
 
   Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2022
   
  
  
  September 28, 2022
  From Benzinga
 
   These Analysts Boost Price Targets On Biogen Following Positive Alzheimer's Drug Data, Shares Jump
   
  September 28, 2022
  Tickers 
   BIIB
  
  
  From Benzinga
 From Benzinga
 
   A Biotech Breakthrough Means Big Gains for These 2 Stocks
   
  
  
  September 28, 2022
  From Motley Fool
 
   12 Health Care Stocks Moving In Wednesday's Pre-Market Session
   
  
  
  September 28, 2022
  From Benzinga
 
   Is iPhone Demand Really Slowing Down?, Lyft Freezes Hiring, Biogen's New Drug Slows Alzheimer's Progression: Top Financial Media Stories Wednesday, Sept. 28
   
  
  
  September 28, 2022
  From Benzinga
 
   What In The World Is Going On With Biogen (BIIB) Shares?
   
  
  
  September 28, 2022
  From Benzinga
 From InvestorPlace
 
   Why Cassava Sciences Shares Are Soaring Higher
   
  
  
  September 28, 2022
  From Benzinga
 
   What's Going On With Eli Lilly Stock Shooting Higher Today
   
  
  
  September 28, 2022
  From Benzinga
 From Benzinga
 
   Nasdaq Futures Slip But S&P 500, Dow Futures Hold Up Ahead Of Market Open — Apple, Biogen Stocks In Focus
   
  
  
  September 28, 2022
  From Benzinga
 
   Here’s why one strategist says the consumer and related stocks might get a second wind
   
  
  
  September 28, 2022
  From MarketWatch
 
   Why Biogen Stock Is Up 40% Today
   
  
  
  September 28, 2022
  From Benzinga
 
   Biogen, Eli Lilly And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
   
  
  
  September 28, 2022
  From Benzinga
 
   2 Sympathy Plays To Watch For In The Wake Of Biogen's Positive Alzheimer's Drug Data
   
  
  
  September 28, 2022
  From Benzinga
 
   US Stock Futures Down Ahead Of Fed Speakers, Economic Data
   
  
  
  September 28, 2022
  From Benzinga
 
   Regulatory approval is next: Mizuho lifts Biogen to buy on news of Alzheimer’s drug success
   
  
  
  September 28, 2022
  From MarketWatch
 
   Eisai shares indicated sharply higher after trial of experimental drug slows Alzheimer’s progression
   
  
  
  September 28, 2022
  From MarketWatch
 
   Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock
   
  
  
  September 28, 2022
  From Benzinga
 
   Alzheimer’s drug from Eisai, Biogen shows promise in large trial
   
  September 27, 2022
  Tickers 
   BIIB
  
  
  From MarketWatch
 
   Elon Musk Twitter Case Deposition Delayed, FTX US Goes Shopping, Spotify's Analyst Sees Audiobooks Immaterial: Top Financial Media Stories Tuesday, Sept. 27
   
  
  
  September 27, 2022
  From Benzinga
 
   DOJ says Biogen agrees to $900 million settlement over allegations of false Medicare claims
   
  September 26, 2022
  Tickers 
   BIIB
  
  Tags
   BIIB
  
  From MarketWatch
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
